Lars Bolund

Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts. / Yang, Zhenzhen; Vajta, Gábor; Xu, Ying et al.
In: Cellular reprogramming, Vol. 18, No. 4, 08.2016, p. 256-63.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Yang, Z, Vajta, G, Xu, Y, Luan, J, Lin, M, Liu, C, Tian, J, Dou, H, Li, Y, Liu, T, Zhang, Y, Li, L, Yang, W, Bolund, L, Yang, H & Du, Y 2016, 'Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts', Cellular reprogramming, vol. 18, no. 4, pp. 256-63. https://doi.org/10.1089/cell.2015.0072

APA

Yang, Z., Vajta, G., Xu, Y., Luan, J., Lin, M., Liu, C., Tian, J., Dou, H., Li, Y., Liu, T., Zhang, Y., Li, L., Yang, W., Bolund, L., Yang, H., & Du, Y. (2016). Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts. Cellular reprogramming, 18(4), 256-63. https://doi.org/10.1089/cell.2015.0072

CBE

Yang Z, Vajta G, Xu Y, Luan J, Lin M, Liu C, Tian J, Dou H, Li Y, Liu T, et al. 2016. Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts. Cellular reprogramming. 18(4):256-63. https://doi.org/10.1089/cell.2015.0072

MLA

Vancouver

Yang Z, Vajta G, Xu Y, Luan J, Lin M, Liu C et al. Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts. Cellular reprogramming. 2016 Aug;18(4):256-63. doi: 10.1089/cell.2015.0072

Author

Yang, Zhenzhen ; Vajta, Gábor ; Xu, Ying et al. / Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts. In: Cellular reprogramming. 2016 ; Vol. 18, No. 4. pp. 256-63.

Bibtex

@article{12b3d929054f49ada5cd19e90c732735,
title = "Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts",
abstract = "Mesenchymal stem cells (MSCs) exhibited self-renewal and less differentiation, making the MSCs promising candidates for adult somatic cell nuclear transfer (SCNT). In this article, we tried to produce genome identical pigs through hand-made cloning (HMC), with MSCs and adult skin fibroblasts as donor cells. MSCs were derived from either adipose tissue or peripheral blood (aMSCs and bMSCs, respectively). MSCs usually showed the expression pattern of CD29, CD73, CD90, and CD105 together with lack of expression of the hematopoietic markers CD34and CD45. Flow cytometry results demonstrated high expression of CD29 and CD90 in both MSC lines, while CD73, CD34, and CD45 expression were not detected. In contrary, in reverse transcription-polymerase chain reaction (RT-PCR) analysis, CD73 and CD34 were detected indicating that human antibodies CD73 and CD34 were not suitable to identify porcine cell surface markers and porcine MSC cellular surface markers of CD34 might be different from other species. MSCs also had potential to differentiate successfully into chondrocytes, osteoblasts, and adipocytes. After HMC, embryos reconstructed with aMSCs had higher blastocyst rate on day 5 and 6 than those reconstructed with bMSCs and fibroblasts (29.6% ± 1.3% and 41.1% ± 1.4% for aMSCs vs. 23.9% ± 1.2% and 35.5% ± 1.6% for bMSCs and 22.1% ± 0.9% and 33.3% ± 1.1% for fibroblasts, respectively). Live birth rate per transferred blastocyst achieved with bMSCs (1.59%) was the highest among the three groups. This article was the first report to compare the efficiency among bMSCs, aMSCs, and fibroblasts for boar cloning, which offered a realistic perspective to use the HMC technology for commercial breeding.",
author = "Zhenzhen Yang and G{\'a}bor Vajta and Ying Xu and Jing Luan and Mufei Lin and Cong Liu and Jianing Tian and Hongwei Dou and Yong Li and Tianbin Liu and Yijie Zhang and Lin Li and Wenxian Yang and Lars Bolund and Huanming Yang and Yutao Du",
year = "2016",
month = aug,
doi = "10.1089/cell.2015.0072",
language = "English",
volume = "18",
pages = "256--63",
journal = "Cellular Reprogramming",
issn = "2152-4971",
publisher = "Mary Ann Liebert Inc. Publishers",
number = "4",

}

RIS

TY - JOUR

T1 - Production of Pigs by Hand-Made Cloning Using Mesenchymal Stem Cells and Fibroblasts

AU - Yang, Zhenzhen

AU - Vajta, Gábor

AU - Xu, Ying

AU - Luan, Jing

AU - Lin, Mufei

AU - Liu, Cong

AU - Tian, Jianing

AU - Dou, Hongwei

AU - Li, Yong

AU - Liu, Tianbin

AU - Zhang, Yijie

AU - Li, Lin

AU - Yang, Wenxian

AU - Bolund, Lars

AU - Yang, Huanming

AU - Du, Yutao

PY - 2016/8

Y1 - 2016/8

N2 - Mesenchymal stem cells (MSCs) exhibited self-renewal and less differentiation, making the MSCs promising candidates for adult somatic cell nuclear transfer (SCNT). In this article, we tried to produce genome identical pigs through hand-made cloning (HMC), with MSCs and adult skin fibroblasts as donor cells. MSCs were derived from either adipose tissue or peripheral blood (aMSCs and bMSCs, respectively). MSCs usually showed the expression pattern of CD29, CD73, CD90, and CD105 together with lack of expression of the hematopoietic markers CD34and CD45. Flow cytometry results demonstrated high expression of CD29 and CD90 in both MSC lines, while CD73, CD34, and CD45 expression were not detected. In contrary, in reverse transcription-polymerase chain reaction (RT-PCR) analysis, CD73 and CD34 were detected indicating that human antibodies CD73 and CD34 were not suitable to identify porcine cell surface markers and porcine MSC cellular surface markers of CD34 might be different from other species. MSCs also had potential to differentiate successfully into chondrocytes, osteoblasts, and adipocytes. After HMC, embryos reconstructed with aMSCs had higher blastocyst rate on day 5 and 6 than those reconstructed with bMSCs and fibroblasts (29.6% ± 1.3% and 41.1% ± 1.4% for aMSCs vs. 23.9% ± 1.2% and 35.5% ± 1.6% for bMSCs and 22.1% ± 0.9% and 33.3% ± 1.1% for fibroblasts, respectively). Live birth rate per transferred blastocyst achieved with bMSCs (1.59%) was the highest among the three groups. This article was the first report to compare the efficiency among bMSCs, aMSCs, and fibroblasts for boar cloning, which offered a realistic perspective to use the HMC technology for commercial breeding.

AB - Mesenchymal stem cells (MSCs) exhibited self-renewal and less differentiation, making the MSCs promising candidates for adult somatic cell nuclear transfer (SCNT). In this article, we tried to produce genome identical pigs through hand-made cloning (HMC), with MSCs and adult skin fibroblasts as donor cells. MSCs were derived from either adipose tissue or peripheral blood (aMSCs and bMSCs, respectively). MSCs usually showed the expression pattern of CD29, CD73, CD90, and CD105 together with lack of expression of the hematopoietic markers CD34and CD45. Flow cytometry results demonstrated high expression of CD29 and CD90 in both MSC lines, while CD73, CD34, and CD45 expression were not detected. In contrary, in reverse transcription-polymerase chain reaction (RT-PCR) analysis, CD73 and CD34 were detected indicating that human antibodies CD73 and CD34 were not suitable to identify porcine cell surface markers and porcine MSC cellular surface markers of CD34 might be different from other species. MSCs also had potential to differentiate successfully into chondrocytes, osteoblasts, and adipocytes. After HMC, embryos reconstructed with aMSCs had higher blastocyst rate on day 5 and 6 than those reconstructed with bMSCs and fibroblasts (29.6% ± 1.3% and 41.1% ± 1.4% for aMSCs vs. 23.9% ± 1.2% and 35.5% ± 1.6% for bMSCs and 22.1% ± 0.9% and 33.3% ± 1.1% for fibroblasts, respectively). Live birth rate per transferred blastocyst achieved with bMSCs (1.59%) was the highest among the three groups. This article was the first report to compare the efficiency among bMSCs, aMSCs, and fibroblasts for boar cloning, which offered a realistic perspective to use the HMC technology for commercial breeding.

U2 - 10.1089/cell.2015.0072

DO - 10.1089/cell.2015.0072

M3 - Journal article

C2 - 27459584

VL - 18

SP - 256

EP - 263

JO - Cellular Reprogramming

JF - Cellular Reprogramming

SN - 2152-4971

IS - 4

ER -